Daily Derm Times: July 14, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Learning From Patient Experiences of Melanoma

Melanoma survivors share their diagnoses and advocate for early detection, routine skin exams, and public education to save lives.

Boehringer Ingleheim, LEO Pharma Announce Partnership to Advance Spesolimab in GPP and Beyond

The pharmaceutical companies announced an exclusive global license and transfer agreement for the advancement and commercialization of Spevigo.

Deuruxolitinib Launches in US for Treatment of Severe Alopecia Areata

Sun Pharmaceuticals has launched deuruxolitinib (Leqselvi) in the US, offering a new treatment for adults with severe alopecia areata.

French Survey Reveals Gaps in CHE Severity Assessment

A national Delphi survey reveals critical insights into CHE management in France, highlighting the need for standardized assessment and guidelines.

Approved Hidradenitis Suppurativa Treatments and Pipeline Show Similar Efficacy, Safety Without Head-to-Head Trials

Both regulatory-approved and pipeline treatments for moderate to severe HS demonstrate comparable efficacy and safety, offering hope for patients often dissatisfied with current treatment options.